Breaks Categories: News

TuesdayMar 10, 2026 9:00 am

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Files Quarterly Report for Quarter Ended Jan. 31, 2026

Uranium Energy (NYSE American: UEC) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended Jan. 31, 2026, highlighting progress across its U.S. in-situ recovery (“ISR”) uranium operations and balance sheet strength. During the quarter, the company completed construction of the Burke Hollow ISR uranium mine, expanded production capacity in Wyoming and South Texas pending final regulatory approvals and advanced feasibility, siting and licensing work for United States Uranium Refining & Conversion Corp. UEC also reported selling uranium at prices more than 25% above the quarterly average while maintaining $818 million in liquid assets and no…

Continue Reading

TuesdayMar 10, 2026 9:00 am

NetworkNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Adopts Shareholder Rights Plan

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has adopted a Shareholder Rights Plan and entered into a Shareholder Rights Plan Agreement with TMX Trust Company as rights agent, effective immediately. The plan, which is consistent with similar measures adopted by Canadian public companies and was not implemented in response to any specific takeover proposal, is designed to provide the company’s board and shareholders adequate time to evaluate any unsolicited takeover bid, explore value-enhancing alternatives and ensure shareholders receive full and fair value. The plan will be subject to…

Continue Reading

TuesdayMar 10, 2026 9:00 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) SGX945 Granted Promising Innovative Medicine Designation in UK for Behçet Disease

Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine (“PIM”) designation from the U.K. Medicines and Healthcare Products Regulatory Agency for the treatment of Behçet’s Disease. The designation represents the first step toward potential inclusion in the U.K.’s Early Access to Medicines Scheme, which allows patients with life-threatening or seriously debilitating conditions to access promising therapies earlier. The PIM designation was granted based on Phase 2 clinical data indicating that dusquetide may provide a significant advantage over existing treatments while demonstrating a favorable potential benefit-risk profile for patients with this rare inflammatory disorder. To view the full…

Continue Reading

TuesdayMar 10, 2026 9:00 am

NetworkNewsBreaks – McEwen Inc. (NYSE: MUX) (TSX: MUX) Announces Q4 and Year-End 2025 Conference Call Scheduled for March 12

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.  McEwen (NYSE: MUX) (TSX: MUX) has invited investors to join its fourth quarter and year-end 2025 conference call scheduled for Thursday, March 12, 2026, at 3:00 p.m. EDT. During the call, management will discuss the company’s financial results and project developments, followed by a question-and-answer session in which participants will be able to submit questions directly by phone during the webcast.  To view the full press release, visit, https://nnw.fm/tOjJR About McEwen  McEwen shares trade on both the NYSE and TSXunder the ticker MUX.  McEwen provides its shareholders with exposure to a growing base of gold and silverproduction in addition…

Continue Reading

MondayMar 09, 2026 9:55 am

NetworkNewsBreaks – Octane Announces Neuro Tech Forum 2026 to Be Held March 26-27 in Newport Beach

Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California, bringing together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The event, part of Octane’s Innovation Event Series, will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape. The forum will include innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster…

Continue Reading

MondayMar 09, 2026 9:39 am

NetworkNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Announces 1-for-3 Reverse Share Split to Maintain Nasdaq Listing Compliance

Wearable Devices (NASDAQ: WLDS), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced it will implement a one-for-three reverse split of its ordinary shares and tradable warrants, effective when trading begins on a split-adjusted basis on March 11, 2026. The action is intended to increase the company’s per-share trading price to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse split, the number of issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, while publicly held warrants will decrease from 98,589 to about 32,863, with…

Continue Reading

MondayMar 09, 2026 9:20 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Operational Environment for Ukraine Field Testing of Overwatch Platform

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced that it has established the operational environment for its Overwatch GPS-denied navigation and targeting platform for the Ukraine market and expects to deliver the system this week as part of operational field testing first announced in February 2026. The testing will evaluate the platform’s navigation and target acquisition capabilities under persistent GPS jamming and degraded signal conditions, providing a key validation milestone for defense and security applications in contested environments. In conjunction with the deployment,…

Continue Reading

MondayMar 09, 2026 9:20 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing advanced cardiac insights, announced that its management team will attend several investor and industry conferences in March 2026. CEO Robert Eno and CFO Timothy Cruickshank will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, including a webcast presentation on March 16, while also meeting with institutional and retail investors. The executives will also attend the 38th Annual ROTH Conference in Dana Point, California, on March 23-24, where Eno will join a panel on technologies advancing healthy aging. In addition, Eno, Founder and President Dr. Branislav Vajdic and…

Continue Reading

MondayMar 09, 2026 9:10 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Palm Beach Clinic for Depression and PTSD Treatment

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focused on treating depression and post-traumatic stress disorder through an interventional psychiatry approach that includes ketamine and other neuroplastic drugs, transcranial magnetic stimulation (TMS), hyperbaric oxygen therapy and physician-led psychotherapy. The facility expands HOPE’s growing network of clinics and builds on a nationwide partnership with neurocare AG to bring non-invasive neuroplastic therapies to patients. Peer-reviewed publications cited by the company report an 87% clinical response rate in treatment-resistant depression using short-term treatment protocols, while pilot programs incorporating hyperbaric oxygen therapy have…

Continue Reading

MondayMar 09, 2026 9:00 am

NetworkNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Mineral Resource Estimate for Kyrgyzstan Gold Projects

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced the filing of an updated Mineral Resource Estimate for the Tulkubash and Kyzyltash Chaarat Gold Projects in the Republic of Kyrgyzstan through a National Instrument 43-101 technical report titled “NI 43-101 Technical Report and Updated Mineral Resource Estimate for the Tulkubash And Kyzyltash Chaarat Gold Project Republic Of Kyrgyzstan,” effective Oct. 15, 2025. The report was prepared in accordance with Canadian Securities Administrators’ National Instrument 43-101 – Standards of Disclosure for Mineral Projects and is available on…

Continue Reading